Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
KERNW Stock Summary
In the News
Akerna Flash Report: Boomers Drive the Edibles Market Among First-time Buyers
Business intelligence from Akerna (KERN), a leading compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), shows among first-time cannabis buyers, baby boomers (55+) spend 22% on edibles versus 9% on edibles for consumers in the18-34-year-old age range. “The image of Jeff Spicoli as the stereotypical stoner has tainted the image of the cannabis consumer,” said Aryeh Primus, vice president of analytics, Akerna. At one time, the use of tinctures, concentrated herbal extracts, were thought to be popular among the Baby Boomer Generation, due to historical medical uses.
Akerna Flash Report: 420 Cannabis Sales Create New Monday Record
Business intelligence from Akerna (KERN), a leading compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), shows sales on 420, a day of celebration for cannabis enthusiasts, made this years’ 420 the biggest Monday in 2020. Sales increased 111% over the previous Monday averages this year.
Akerna Corp. Reports Second Quarter Fiscal Year 2020 Results
DENVER, Feb. 12, 2020 -- Akerna Corp. (Nasdaq: KERN, KERNW), a leading cannabis compliance technology provider and developer of the cannabis industry’s first seed-to-sale.
American Cannabis Stocks Are Working Their Way To Wall Street
Direct cannabis operators in the U.S. are limited to the OTC, which prevents many investors from buying shares, but we are beginning to see several companies that provide them goods or services obtain NYSE or NASDAQ listings
Akerna Completes Acquisition of Majority Interest in Anti-Counterfeiting Technology Leader solo sciences
Akerna (KERN), a leading cannabis compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), has completed its acquisition of a majority interest in privately-held solo sciences inc., a recognized leader of patented anti-counterfeiting and consumer engagement technologies. Leaf Data Systems, Akerna’s government track and trace software, won the first state cannabis tracking system Request for Proposal (RFP) to which Akerna responded with solo*TAG included.
Akerna Names John Fowle CFO
DENVER, Dec. 23, 2019 -- Akerna (Nasdaq: KERN), a leading cannabis compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise.
solo sciences and 14th Round Team Up to Protect Consumers from Counterfeit Products
DENVER, Dec. 09, 2019 (GLOBE NEWSWIRE) -- solo sciences, an Akerna company (KERN), the world’s first cryptographically-secured product authentication system, has entered into an agreement with leading cannabis design and technology firm, 14th Round to add its solo*CODE authentication tag to its vaporizer brands. The deal further advances solo’s efforts to address regulatory compliance throughout the entire supply chain, enhancing product safety for consumers. Thanks to this collaboration, solo sciences trust mark authentication will be a default feature for 14th Round’s high-profile cannabis vaporizer brands.
Akerna Names Alex Shah CTO
Akerna Corp. (Nasdaq: KERN), a leading cannabis compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), has named Ashesh C. Shah (Alex), chief technology officer (CTO). As CTO, Alex will leverage his more than 20 years of expertise in IP, licensing, consumer loyalty, couponing and payment technology, category management, data analytics, and AI to help Akerna set the new industry standard for supply accountability and transparency. Having a proven technology veteran like Alex as our CTO is expected to help us do just that, further helping us build upon recent operational momentum.
Akerna Makes $18M Investment in Anti-Counterfeiting Technology Leader solo sciences
To strengthen its leading technology platform and increase transparency in the global cannabis supply chain, Akerna (Nasdaq: KERN), a leading cannabis compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), has taken a majority stake in privately-held solo sciences inc., a recognized leader of patented anti-counterfeiting and consumer engagement technologies. The investment is another step in Akerna’s commitment to creating the pre-eminent global technology platform to address the entire supply chain and its regulatory bodies through accountability and transparency.
Akerna Corp. Issues Letter to Shareholders
Akerna (Nasdaq: KERN, KERNW) (“Akerna” or the “Company”), a leading cannabis compliance technology company, today announced the following letter from its Chief Executive Officer, Jessica Billingsley, to its shareholders and the investment community.
KERNW Financial details
KERNW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
|Revenue per share||0||0||36.13||16.13||4.66|
|Net income per share||0||-0.29||-40.71||-26.18||-20.02|
|Operating cash flow per share||0||-5.92||-29.94||-6.03||-3.72|
|Free cash flow per share||0||-5.92||-40.72||-10.3||-5.22|
|Cash per share||0||0.04||72.34||10.87||0.3|
|Book value per share||0||564.67||73.05||45||-1.65|
|Tangible book value per share||0||564.67||-27.45||-12.41||-3.19|
|Share holders equity per share||0||564.67||73.05||45||-1.65|
|Interest debt per share||0||-9.25||54.04||-1.18K||5.28|
|Price to sales ratio||0||0||4.87||2.17||0.15|
|EV to sales||0||0||4.37||2.33||1.15|
|Enterprise value over EBITDA||0||-23.1||-3.84||-36.1||-1.34|
|EV to operating cash flow||0||-34.08||-5.27||-6.24||-1.44|
|EV to free cash flow||0||-34.08||-3.87||-3.65||-1.03|
|Free cash flow yield||0||-0.03||-0.23||-0.29||-7.56|
|Debt to equity||5.55||0||0.74||0.3||-3.03|
|Debt to assets||0.81||0||0.67||0.19||0.75|
|Net debt to EBITDA||0||0||0.45||-2.52||-1.17|
|Sales general and administrative to revenue||0||0||1.2||0.5||0.61|
|Research and developement to revenue||0||0||0.51||0.3||0.34|
|Intangibles to total assets||0||0||1.24||0.8||0.23|
|Capex to operating cash flow||0||0||0.36||0.71||0.4|
|Capex to revenue||0||0||-0.3||-0.26||-0.32|
|Capex to depreciation||0||0||-2.48||-0.95||-0.56|
|Stock based compensation to revenue||0||0||0.36||0.1||0.06|
|Return on tangible assets||0||0||2.1||-1.8||-3.92|
|Tangible asset value||23.44K||58.08M||-8.3M||-15.91M||-9.35M|
|Net current asset value||-111.04K||-370.75K||22.08M||-16.3M||-9.4M|
|Days sales outstanding||0||0||52.74||24.77||18.05|
|Days payables outstanding||0||0||103.78||272.58||298.51|
|Days of inventory on hand||0||0||0||124.71||818.02|
|Capex per share||0||0||-10.78||-4.26||-1.5|
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
|Revenue per share||3.43||1.39||0.63||0.49||0.38|
|Net income per share||-16.67||-0.59||-2.6||-0.46||-0.52|
|Operating cash flow per share||-2.03||-0.84||-0.1||-0.47||-0.26|
|Free cash flow per share||-2.66||-1.25||-0.33||-0.47||-0.26|
|Cash per share||2.89||0.64||0.19||0.16||0.14|
|Book value per share||7.3||5.17||-1.07||-1.08||-1.37|
|Tangible book value per share||-11.66||-3.08||-2.07||-1.87||-2.03|
|Share holders equity per share||7.3||5.17||-1.07||-1.08||-1.37|
|Interest debt per share||7.67||3.83||3.29||1.49||1.68|
|Price to sales ratio||0.8||1.29||1.09||1.65||1.58|
|EV to sales||2.16||3.51||5.92||4.56||5.7|
|Enterprise value over EBITDA||0.63||-4.02||-7.02||-7.36||-22.21|
|EV to operating cash flow||-3.65||-5.81||-37.45||-4.68||-8.4|
|EV to free cash flow||-2.79||-3.91||-11.42||-4.68||-8.4|
|Free cash flow yield||-0.96||-0.69||-0.47||-0.59||-0.43|
|Debt to equity||1.03||0.72||-3.03||-1.46||-1.26|
|Debt to assets||0.31||0.32||0.75||1.21||1.6|
|Net debt to EBITDA||0.39||-2.54||-5.72||-4.7||-16.06|
|Sales general and administrative to revenue||0.4||0.34||0.68||0.6||0.65|
|Research and developement to revenue||0.29||0.25||0.26||0.32||0.29|
|Intangibles to total assets||0.78||0.7||0.23||0.61||0.62|
|Capex to operating cash flow||0.31||0.49||2.28||0||0|
|Capex to revenue||-0.18||-0.29||-0.36||0||0|
|Capex to depreciation||-0.56||-0.75||-0.59||0||0|
|Stock based compensation to revenue||0.03||0.04||0.06||0.04||0.05|
|Return on tangible assets||-3.1||-0.17||-0.79||-0.9||-1.26|
|Tangible asset value||-20.67M||-11.95M||-9.35M||-10.03M||-12.13M|
|Net current asset value||-21.05M||-12.3M||-9.4M||-10.07M||-12.17M|
|Days sales outstanding||38.67||36.79||21.33||29.6||29.47|
|Days payables outstanding||185.94||55.74||321.97||150.78||163.35|
|Days of inventory on hand||66.27||359.43||882.3||56.48||56.5|
|Capex per share||-0.63||-0.41||-0.23||0||0|
KERNW Frequently Asked Questions
What is Akerna Corp. stock symbol ?
Akerna Corp. is a US stock and trading under the symbol KERNW
What is Akerna Corp. stock quote today ?
Akerna Corp. stock price is $0.0106 today.
Is Akerna Corp. stock public?
Yes, Akerna Corp. is a publicly traded company.